CCM
MED icon

Candlestick Capital Management’s Medifast MED Stock Holding History

Candlestick Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-77,037
Closed -$13.2M – 111
2022
Q1 		$13.2M Buy
+77,037
New +$14.5M 0.34% 76
2021
Q4 		– Sell
-109,220
Closed -$21M – 138
2021
Q3 		$21M Buy
+109,220
New +$26.8M 0.4% 79

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Candlestick Capital Management's MED Position: Q2 2022 in Review

Candlestick Capital Management sold out of Medifast (MED) in Q2 2022, closing a stake of 77,037 shares — an estimated $13.2M sold.

Candlestick Capital Management first reported a position in MED in Q3 2021 and held it in 2 quarters. The position peaked at $21M in Q3 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

  • Candlestick Capital Management reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
  • Candlestick Capital Management sold 77,037 Medifast shares in Q2 2022, an estimated $13.2M.
  • Candlestick Capital Management first reported a position in Medifast in Q3 2021 and held it in 2 quarters.
  • Candlestick Capital Management's Medifast position peaked at $21M in Q3 2021.
  • 284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Candlestick Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.